QPS-Qualitix Clinical Research

QPS‑Qualitix Clinical Research, a subsidiary of QPS Holdings since its acquisition in March 2011, operates as a full-service contract research organization based in Taipei, Taiwan. It provides comprehensive clinical trial services across phases I–IV with expertise spanning infectious diseases, respiratory conditions, cardiovascular disease, oncology, immunology and more. The company has supported global pharmaceutical clients such as Boehringer Ingelheim, GlaxoSmithKline, Novartis and Roche. Its pipeline includes at least one Phase 3 asset ("Formosa 1-Breath Free" for influenza). The company also offers site management through its subsidiary Unitix.